Cancer Research Archive — Page 1 of 3

Illustration of a large yellow cell surrounded by several smaller blue cells in a fluid-like environment, depicting immune-cell interactions.
January 16, 2024

Data haul improves immunotherapy response prediction

Vanderbilt biostatisticians have developed an immunotherapy response model that outperforms existing predictive models.

By Paul Govern
Exterior of Vanderbilt-Ingram Cancer Center’s Frances Williams Preston Building, a brick-and-glass research building with a covered entrance and elevated pedestrian bridge.
August 10, 2023

New leaders named to Vanderbilt-Ingram research programs

Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center’s research programs.

By Tom Wilemon
Head-and-shoulders portrait of a smiling woman with long brown hair, wearing a blue-and-white patterned blouse against a brown background.
June 21, 2023

Three Vanderbilt physicians named ASCO fellows

Three Vanderbilt-Ingram Cancer Center physicians were recently named fellows of the American Society of Clinical Oncology.

By Tom Wilemon
Head-and-shoulders portrait of a smiling woman with shoulder-length brown hair wearing a dark blazer outdoors in a leafy setting.
May 10, 2022

New study illustrates how much it would cost for cancer drugs covered under Medicare Part D

A new study by Vanderbilt researchers highlights how some older Americans diagnosed with cancer can face unlimited out-of-pocket spending for prescription drugs under the current structure of the Medicare Part D benefit.

By Jake Lowary
P. Brent Ferrell, MD, is part of a multidisciplinary team studying new approaches to understand and treat cancer.
March 17, 2022

Ferrell lands Mark Foundation for Cancer Research award

Vanderbilt’s Brent Ferrell, MD, is one of the recipients a 2022 Endeavor Award from the The Mark Foundation for Cancer Research.

By Tom Wilemon
Artistic depiction of CRISPR-Cas9 genome editing, showing large textured cell-like forms surrounded by DNA strands, with red and blue strands intertwined across their surfaces.
January 14, 2022

Vanderbilt biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy

A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors.

By Tom Wilemon